What is the current Ipsen market capitalization?
The current market capitalization of Ipsen is 9.43 B EUR.
Ipsen Market capitalization 2024
Ipsen Market capitalization
9.43 B EUR
Ticker
IPN.PA
ISIN
FR0010259150
WKN
A0ESMG
In 2024, Ipsen's market cap stood at 9.43 B EUR, a 7.16% increase from the 8.8 B EUR market cap in the previous year.
The Ipsen Market capitalization history
| YEAR | Market Capitalization (undefined EUR) |
|---|---|
| 2023 | 9.18 |
| 2022 | 8.12 |
| 2021 | 6.79 |
| 2020 | 6.12 |
| 2019 | 8.76 |
| 2018 | 10.7 |
| 2017 | 8.46 |
| 2016 | 4.7 |
| 2015 | 4.32 |
| 2014 | 2.86 |
| 2013 | 2.38 |
| 2012 | 1.7 |
| 2011 | 1.99 |
| 2010 | 2.57 |
| 2009 | 2.76 |
| 2008 | 2.92 |
| 2007 | 3.17 |
| 2006 | 2.56 |
| 2005 | 2.01 |
| 2004 | - |
Ipsen Aktienanalyse
What does Ipsen do?
Ipsen SA is a French biopharmaceutical company specialized in the development of drugs for the treatment of cancer, neurological disorders, and endocrine disorders. It was founded in 1929 by a pharmacist named Henri Beaufour and is headquartered in Paris. The history of Ipsen began with the production of extraction products from snake venom for the manufacturing of serum against tetanus and diphtheria. In the 1960s, the company started to focus on the production of hormones and peptides, with a focus on endocrine disorders. In the 1990s, Ipsen expanded its product portfolio to include oncology and neurological disorders. Ipsen's business model focuses on research and development of new drugs, as well as marketing of already established drugs in selected markets worldwide. The company employs around 5,700 employees and operates in more than 115 countries. Ipsen has two main business segments: specialty drugs and consumer healthcare. The specialty drugs segment focuses on the development and marketing of innovative therapies in the areas of oncology, endocrinology, and neuroscience. Ipsen's most well-known products include Somatuline, a drug for the treatment of acromegaly, and Decapeptyl, a drug for the treatment of prostate cancer and endometriosis. In the consumer healthcare segment, Ipsen is mainly specialized in the production of drugs for the treatment of gastrointestinal disorders and cold and flu symptoms. Some well-known brands include Smecta, a drug for diarrhea, and Nurofen, a pain reliever. Ipsen also has a strong presence in the field of aesthetic medicine, where the company operates a subsidiary called Ipsen Aesthetic. This subsidiary develops and markets products for the treatment of wrinkles and other signs of aging on the skin. Well-known brands of Ipsen Aesthetic include Dysport, a botulinum toxin product for the treatment of wrinkles, and the filler Restylane. Overall, Ipsen has established itself as a leading biopharmaceutical company focused on the development and marketing of products in specialized therapy areas. The company has a strong pipeline of new products in development and remains an important player in the pharmaceutical industry due to its strong scientific expertise and global presence. Ipsen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Ipsen's Market Capitalization
Ipsen's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Ipsen's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Ipsen's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Ipsen’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Ipsen stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Ipsen.
How has the market capitalization of Ipsen developed in recent years?
The market capitalization of Ipsen has increased/decreased by 7.16% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Ipsen?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Ipsen?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Ipsen have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Ipsen pay?
Over the past 12 months, Ipsen paid a dividend of 1.2 EUR . This corresponds to a dividend yield of about 1.06 %. For the coming 12 months, Ipsen is expected to pay a dividend of 1.4 EUR.
What is the dividend yield of Ipsen?
The current dividend yield of Ipsen is 1.06 %.
When does Ipsen pay dividends?
Ipsen pays a quarterly dividend. This is distributed in the months of June, June, July, June.
How secure is the dividend of Ipsen?
Ipsen paid dividends every year for the past 24 years.
What is the dividend of Ipsen?
For the upcoming 12 months, dividends amounting to 1.4 EUR are expected. This corresponds to a dividend yield of 1.24 %.
In which sector is Ipsen located?
Ipsen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ipsen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ipsen from 6/3/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2024.
When did Ipsen pay the last dividend?
The last dividend was paid out on 6/3/2024.
What was the dividend of Ipsen in the year 2023?
In the year 2023, Ipsen distributed 1.2 EUR as dividends.
In which currency does Ipsen pay out the dividend?
The dividends of Ipsen are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Ipsen stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Ipsen
Our stock analysis for Ipsen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ipsen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
